Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

981 - 990 of 3598 results found

Study of Pharmacokinetics for Ivermectin B1a from Beagle Dogs

Date
Friday, December 22, 2023 - 4:00 AM
Description
Ivermectin has been widely used for antiparasitic drug, and has recently shown a broad-spectrum antiviral activity, including anti-Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacokinetic property of ivermectin has

Searching for New Biomarkers to Assess COVID-19 Patients: A Pilot Study

Date
Friday, December 22, 2023 - 4:00 AM
Description
During the initial diagnosis of urgent medical conditions, which include acute infectious diseases, it is important to assess the severity of the patient's clinical state as quickly as possible. Unlike individual biochemical or physiological

SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals

Date
Thursday, December 21, 2023 - 4:00 AM
Description
Early treatment with a first-line therapy (nirmatrelvir/ritonavir [Paxlovid] or remdesivir) or second-line therapy (molnupiravir) prevents hospitalization and death among patients with mild-to-moderate COVID-19 who are at risk for severe disease and

SARS-CoV-2 RNA stabilizes host mRNAs to elicit immunopathogenesis

Date
Thursday, December 21, 2023 - 4:00 AM
Description
SARS-CoV-2 RNA interacts with host factors to suppress interferon responses and simultaneously induces cytokine release to drive the development of severe coronavirus disease 2019 (COVID-19). However, how SARS-CoV-2 hijacks host RNAs to elicit such